Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Non Operating Investment Income (2023 - 2026)

Rallybio's Non Operating Investment Income history spans 3 years, with the latest figure at -$6000.0 for Q4 2025.

  • On a quarterly basis, Non Operating Investment Income rose 94.06% to -$6000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$50000.0, a 194.34% decrease, with the full-year FY2025 number at -$50000.0, down 194.34% from a year prior.
  • Non Operating Investment Income hit -$6000.0 in Q4 2025 for Rallybio, down from $7000.0 in the prior quarter.
  • Over the last five years, Non Operating Investment Income for RLYB hit a ceiling of $240000.0 in Q3 2024 and a floor of -$211000.0 in Q2 2023.
  • Historically, Non Operating Investment Income has averaged $21090.9 across 3 years, with a median of -$6000.0 in 2025.
  • The widest YoY moves for Non Operating Investment Income: up 275.0% in 2024, down 156.21% in 2024.
  • Tracing RLYB's Non Operating Investment Income over 3 years: stood at $223000.0 in 2023, then crashed by 145.29% to -$101000.0 in 2024, then skyrocketed by 94.06% to -$6000.0 in 2025.
  • Business Quant data shows Non Operating Investment Income for RLYB at -$6000.0 in Q4 2025, $7000.0 in Q3 2025, and -$30000.0 in Q2 2025.